Identifying individuals with MODY in Africa may be helpful to correctly selecting individuals who may transition from over-treatment with insulin (which is expensive, requiring multiple daily injections and glucose monitoring) to cheap oral antidiabetic tablets that are readily available, affordable, easy to administer and generally accepted by most patients. The gene discussed is INS; the disease is MODY.